Earnings
-
Guardant buys MetaSight for $59M upfront to acquire blood test tech
MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.
By Nick Paul Taylor • Feb. 23, 2026 -
Medtronic completes first Hugo case in the US
CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing “pretty fast.”
By Ricky Zipp • Feb. 17, 2026 -
Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
By Elise Reuter • Feb. 13, 2026 -
Zimmer plans US salesforce reorganization
Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.
By Elise Reuter • Feb. 11, 2026 -
Edwards focuses on earlier TAVR adoption
The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.
By Susan Kelly • Feb. 11, 2026 -
GE HealthCare expects smaller tariff impact in 2026
After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.
By Elise Reuter • Feb. 5, 2026 -
Boston Scientific continues to see electrophysiology success despite slowdown in growth
Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years. However, the pace has slowed in recent quarters.
By Ricky Zipp • Feb. 4, 2026 -
Stryker starts first cases with handheld ortho robot
Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.
By Elise Reuter • Jan. 30, 2026 -
Intuitive pushes into cardiac robotic surgery, ASCs
The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.
By Susan Kelly • Jan. 23, 2026 -
Abbott posts Q4 sales below expectations
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.
By Elise Reuter • Jan. 22, 2026 -
J&J’s cardiovascular business boosts medtech growth in 2025
Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.
By Ricky Zipp • Jan. 21, 2026 -
Intuitive says general surgery, acute care fuel US robot momentum
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.
By Susan Kelly • Jan. 16, 2026 -
Medtronic’s PFA business is heating up
Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s 2026 fiscal year, amid mounting competition in the space.
By Ricky Zipp • Nov. 18, 2025 -
Vicarious says it will outsource some robot development functions
The initiative is part of a restructuring to preserve cash while the company completes the design of the robotic surgery system it plans to commercialize.
By Susan Kelly • Nov. 14, 2025 -
MMI tackles Alzheimer’s; SS Innovations advances telesurgery
MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.
By Susan Kelly • Nov. 10, 2025 -
Illumina says China is lifting export ban
However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term resolution of the issue.
By Susan Kelly • Nov. 6, 2025 -
Siemens Healthineers predicts tariff impact will double
The company expects to fully offset the negative effects of tariffs in the medium term.
By Nick Paul Taylor • Nov. 6, 2025 -
Zimmer CEO ‘very surprised’ by Q3 sales miss
CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall.
By Elise Reuter • Nov. 5, 2025 -
Edwards CFO Scott Ullem to exit post
Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.
By Susan Kelly • Oct. 31, 2025 -
Dexcom execs say company has fixed G7 quality problems
After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.
By Elise Reuter • Oct. 31, 2025 -
Boston Scientific continues to win in electrophysiology
Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.
By Ricky Zipp • Oct. 22, 2025 -
Intuitive Surgical reports strong Q3 as da Vinci procedures climb
Intuitive Surgical’s shares surged nearly 15% early Wednesday after the robot maker’s third-quarter sales and earnings topped analysts’ expectations.
By Susan Kelly • Oct. 22, 2025 -
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
By Elise Reuter • Oct. 15, 2025 -
Medtech firms splitting into ‘haves’ and ‘have-nots’: EY
The number of medtech funding rounds has declined in recent months, but the value of overall deals has increased, according to a new report from EY.
By Elise Reuter • Sept. 29, 2025 -
Medtronic adds 2 board seats, forms special committees
CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.
By Ricky Zipp • Aug. 19, 2025